Raimondo, D.; Miscia, M.; Raffone, A.; Maletta, M.; Cipriani, L.; Marchese, P.V.; Comito, F.; Vicenti, R.; Cortese, F.; Pazzaglia, E.;
et al. Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis. Curr. Oncol. 2025, 32, 702.
https://doi.org/10.3390/curroncol32120702
AMA Style
Raimondo D, Miscia M, Raffone A, Maletta M, Cipriani L, Marchese PV, Comito F, Vicenti R, Cortese F, Pazzaglia E,
et al. Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis. Current Oncology. 2025; 32(12):702.
https://doi.org/10.3390/curroncol32120702
Chicago/Turabian Style
Raimondo, Diego, Michele Miscia, Antonio Raffone, Manuela Maletta, Linda Cipriani, Paola Valeria Marchese, Francesca Comito, Rossella Vicenti, Federica Cortese, Enrico Pazzaglia,
and et al. 2025. "Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis" Current Oncology 32, no. 12: 702.
https://doi.org/10.3390/curroncol32120702
APA Style
Raimondo, D., Miscia, M., Raffone, A., Maletta, M., Cipriani, L., Marchese, P. V., Comito, F., Vicenti, R., Cortese, F., Pazzaglia, E., Bertoldo, L., Cobellis, L., & Seracchioli, R.
(2025). Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis. Current Oncology, 32(12), 702.
https://doi.org/10.3390/curroncol32120702
